Related Experiment Video
Updated: Sep 26, 2026

Multiplexed Live-Cell Imaging for Drug Responses in Patient-Derived Organoid Models of Cancer
Published on: January 5, 2024
NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells
Sukhdev S Brar1, Zachary Corbin, Thomas P Kennedy
1Department of Internal Medicine, Carolinas Medical Center, Charlotte, NC 28232, USA.
Abstract:
Reactive oxygen species (ROS) appear to play an important role in regulating growth and survival of prostate cancer. However, the sources for ROS production in prostate cancer cells have not been determined. We report that ROS are generated by intact American Type Culture Collection DU 145 cells and by their membranes through a mechanism blocked by NAD(P)H oxidase inhibitors. ROS are critical for growth in these cells, because NAD(P)H oxidase inhibitors and antioxidants blocked proliferation. Components of the human phagocyte NAD(P)H oxidase, p22phox and gp91phox, as well as the Ca2+ concentration-responsive gp91phox homolog NOX5 were demonstrated in DU 145 cells by RT-PCR and sequencing. Although the protein product for p22phox was not detectable, both gp91phox and NOX5 were identified throughout the cell by immunostaining and confocal microscopy and NOX5 immunostaining was enhanced in a perinuclear location, corresponding to enhanced ROS production adjacent to the nuclear membrane imaged by 2',7'-dichlorofluorescin diacetate oxidation. The calcium ionophore ionomycin dramatically stimulated ferricytochrome c reduction in cell media, further supporting the importance of NOX5 for ROS production. Antisense oligonucleotides for NOX5 inhibited ROS production and cell proliferation in DU 145 cells. In contrast, antisense oligonucleotides to p22phox or gp91phox did not impair cell growth. Inhibition of ROS generation with antioxidants or NAD(P)H oxidase inhibitors increased apoptosis in cells. These results indicate that ROS generated by the newly described NOX5 oxidase are essential for prostate cancer growth, possibly by providing trophic intracellular oxidant tone that retards programmed cell death.
Insights
Reactive oxygen species (ROS) are crucial for prostate cancer growth. The NOX5 oxidase enzyme generates these ROS, making it a potential target for cancer therapies.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- Reactive oxygen species (ROS) are implicated in prostate cancer progression.
- The specific sources of ROS production within prostate cancer cells remain largely undetermined.
Purpose of the Study:
- To identify the source of ROS production in prostate cancer cells.
- To investigate the role of ROS in prostate cancer cell proliferation and survival.
Main Methods:
- Utilized RT-PCR, sequencing, immunostaining, and confocal microscopy to identify ROS-producing enzymes.
- Employed NAD(P)H oxidase inhibitors, antioxidants, and antisense oligonucleotides to modulate ROS production and assess cellular responses.
- Measured ROS production using 2',7'-dichlorofluorescin diacetate oxidation and ferricytochrome c reduction.
Main Results:
- DU 145 prostate cancer cells generate ROS via a mechanism inhibited by NAD(P)H oxidase inhibitors.
- The NOX5 oxidase was identified as the primary source of ROS essential for cell proliferation.
- Inhibition of NOX5-derived ROS production significantly reduced cell growth and increased apoptosis.
Conclusions:
- NOX5-driven ROS production is essential for prostate cancer cell growth and survival.
- Targeting NOX5 may represent a novel therapeutic strategy for prostate cancer.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Ras Gene
Ras is a superfamily...
The Intrinsic Apoptotic Pathway
Apoptosis